BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35880750)

  • 1. Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility.
    Ayfan AKS; Macdonald J; Irwin AD; Zowawi HM; Forde BM; Paterson DL; Lahra MM; Whiley DM
    J Antimicrob Chemother; 2022 Oct; 77(11):2933-2936. PubMed ID: 35880750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Cas13a-based assays for
    Allan-Blitz L-T; Shah P; Adams G; Branda JA; Klausner JD; Goldstein R; Sabeti PC; Lemieux JE
    mSphere; 2023 Oct; 8(5):e0041623. PubMed ID: 37732792
    [No Abstract]   [Full Text] [Related]  

  • 3. A real-time PCR assay for direct characterization of the Neisseria gonorrhoeae GyrA 91 locus associated with ciprofloxacin susceptibility.
    Buckley C; Trembizki E; Donovan B; Chen M; Freeman K; Guy R; Kundu R; Lahra MM; Regan DG; Smith H; Whiley DM;
    J Antimicrob Chemother; 2016 Feb; 71(2):353-6. PubMed ID: 26538505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae.
    Ebeyan S; Windsor M; Bordin A; Mhango L; Erskine S; Trembizki E; Mokany E; Tan LY; Whiley D;
    J Antimicrob Chemother; 2019 Jul; 74(7):1820-1824. PubMed ID: 30897201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Neisseria gonorrhoeae susceptibility to ciprofloxacin in clinical specimens from men using a real-time PCR assay.
    Magooa MP; Müller EE; Gumede L; Lewis DA
    Int J Antimicrob Agents; 2013 Jul; 42(1):63-7. PubMed ID: 23623337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapy.
    Pond MJ; Hall CL; Miari VF; Cole M; Laing KG; Jagatia H; Harding-Esch E; Monahan IM; Planche T; Hinds J; Ison CA; Chisholm S; Butcher PD; Sadiq ST
    J Antimicrob Chemother; 2016 Apr; 71(4):897-902. PubMed ID: 26817487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct real-time PCR-based detection of Neisseria gonorrhoeae 23S rRNA mutations associated with azithromycin resistance.
    Trembizki E; Buckley C; Donovan B; Chen M; Guy R; Kaldor J; Lahra MM; Regan DG; Smith H; Ward J; Whiley DM
    J Antimicrob Chemother; 2015 Dec; 70(12):3244-9. PubMed ID: 26338048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex real-time PCR assays for the prediction of cephalosporin, ciprofloxacin and azithromycin antimicrobial susceptibility of positive Neisseria gonorrhoeae nucleic acid amplification test samples.
    Peterson SW; Martin I; Demczuk W; Barairo N; Naidu P; Lefebvre B; Allen V; Hoang L; Hatchette TF; Alexander D; Tomas K; Trubnikov M; Wong T; Mulvey MR
    J Antimicrob Chemother; 2020 Dec; 75(12):3485-3490. PubMed ID: 32830242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neisseria gonorrhoeae diagnostic escape from a gyrA-based test for ciprofloxacin susceptibility and the effect on zoliflodacin resistance: a bacterial genetics and experimental evolution study.
    Rubin DH; Mortimer TD; Grad YH
    Lancet Microbe; 2023 Apr; 4(4):e247-e254. PubMed ID: 36868257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of gyrA and parC mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by use of oligonucleotide biochip technology.
    Zhou W; Du W; Cao H; Zhao J; Yang S; Li W; Shen Y; Zhang S; Du W; Zhang X
    J Clin Microbiol; 2004 Dec; 42(12):5819-24. PubMed ID: 15583317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Assay for Detection of Genetic Markers Associated with Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeae.
    Peterson SW; Martin I; Demczuk W; Bharat A; Hoang L; Wylie J; Allen V; Lefebvre B; Tyrrell G; Horsman G; Haldane D; Garceau R; Wong T; Mulvey MR
    J Clin Microbiol; 2015 Jul; 53(7):2042-8. PubMed ID: 25878350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex Real-Time PCR Assay for Simultaneous Identification of Neisseria gonorrhoeae and Its Ciprofloxacin Susceptibility Status.
    Perera SR; Khan NH; Martin I; Taheri A; Parti RP; Levett PN; Horsman GB; Kusalik A; Dillon JR
    J Clin Microbiol; 2017 Nov; 55(11):3201-3209. PubMed ID: 28814585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mismatch Amplification Mutation Assay-Based Real-Time PCR for Rapid Detection of Neisseria gonorrhoeae and Antimicrobial Resistance Determinants in Clinical Specimens.
    Donà V; Smid JH; Kasraian S; Egli-Gany D; Dost F; Imeri F; Unemo M; Low N; Endimiani A
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29950339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multisite implementation of a real-time polymerase chain reaction assay to predict ciprofloxacin susceptibility in Neisseria gonorrhoeae.
    Ellis O; Hemarajata P; Shahkolahi A; Masinde G; Buchs K; Humphries RM; Klausner JD
    Diagn Microbiol Infect Dis; 2019 Jul; 94(3):213-217. PubMed ID: 30723007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of Neisseria gonorrhoeae is a continuing challenge for molecular detection of gonorrhoea: false negative gonococcal porA mutants are spreading internationally.
    Ison CA; Golparian D; Saunders P; Chisholm S; Unemo M
    Sex Transm Infect; 2013 May; 89(3):197-201. PubMed ID: 23241969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada.
    Ng LK; Sawatzky P; Martin IE; Booth S
    Sex Transm Dis; 2002 Dec; 29(12):780-8. PubMed ID: 12466720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the SpeeDx ResistancePlus® GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae.
    Hadad R; Cole MJ; Ebeyan S; Jacobsson S; Tan LY; Golparian D; Erskine S; Day M; Whiley D; Unemo M;
    J Antimicrob Chemother; 2021 Jan; 76(1):84-90. PubMed ID: 32929456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the viasure Neisseria gonorrhoeae ciprofloxacin resistant assay for the simultaneous identification and direct detection of ciprofloxacin susceptibility.
    Sánchez NO; Pérez NF; Martínez SB
    Diagn Microbiol Infect Dis; 2022 Dec; 104(4):115798. PubMed ID: 36215941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous Detection of Neisseria gonorrhoeae and Fluoroquinolone Resistance Mutations to Enable Rapid Prescription of Oral Antibiotics.
    de Korne-Elenbaas J; Pol A; Vet J; Dierdorp M; van Dam AP; Bruisten SM
    Sex Transm Dis; 2020 Apr; 47(4):238-242. PubMed ID: 32022739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.